Patrick J. McEnany, President and CEO at CATALYST PHARMACEUTICALS, INC. (CPRX), bought 105,300 shares at $0.65 ($68K) on 2016-06-14, disclosed to the SEC on 2016-06-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| CPRX | SELL | 2024-11-15 | $4.1M | — | Filing → |
| CPRX | SELL | 2024-11-13 | $13.1M | — | Filing → |
| CPRX | SELL | 2023-05-17 | $692K | — | Filing → |